Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chintan Parekh

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Frontiers in Oncology|December 20, 2021
Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic LeukemiaYongsheng Ruan, Hye Na Kim, Heather A Ogana, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
A K27-linked Ubiquitin Checkpoint Controls NOTCH HomeostasisBehzad Mansoori, Ying Song, Tian Zhang, et al.
Blood|March 29, 2020
Integrin α6 mediates the drug resistance of acute lymphoblastic B-cell leukemiaEun Ji Gang, Hye Na Kim, Yao-Te Hsieh, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Frontiers in Oncology|December 20, 2021
Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic LeukemiaYongsheng Ruan, Hye Na Kim, Heather A Ogana, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
A K27-linked Ubiquitin Checkpoint Controls NOTCH HomeostasisBehzad Mansoori, Ying Song, Tian Zhang, et al.
Blood|March 29, 2020
Integrin α6 mediates the drug resistance of acute lymphoblastic B-cell leukemiaEun Ji Gang, Hye Na Kim, Yao-Te Hsieh, et al.
Pageof 4